United Services Automobile Association Sangamo Therapeutics, Inc Transaction History

United Services Automobile Association

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$9.05 - $12.22 $146,999 - $198,489	-16,243 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$9.51 - $16.6 $380,723 - $664,564	-40,034 Reduced 71.14%	16,243 $186,000
Q3 2018 Nov 13, 2018	SELL	$13.05 - $19.05 $17,695 - $25,831	-1,356 Reduced 2.35%	56,277 $954,000
Q2 2018 Sep 27, 2018	SELL	$13.9 - $19.8 $3.06 Million - $4.36 Million	-220,056 Reduced 79.25%	57,633 $818,000
Q2 2018 Aug 10, 2018	BUY	$13.9 - $19.8 $3.13 Million - $4.45 Million	224,916 Added 426.2%	277,689 $9.92 Million
Q1 2018 May 14, 2018	BUY	$16.7 - $26.35 $76,369 - $120,498	4,573 Added 9.49%	52,773 $1 Million
Q4 2017 Feb 14, 2018	SELL	$11.6 - $17.35 $1.2 Million - $1.8 Million	-103,600 Reduced 68.25%	48,200 $790,000
Q3 2017 Nov 14, 2017	BUY	$8.4 - $15.0 $1.28 Million - $2.28 Million	151,800	151,800 $2.28 Million

141

60.4M

1.46M

1.84M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $136M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.